TPM News

A group of Republican governors met with Republican members of the Senate Finance Committee on Thursday, and some expressed concerns about the number of people who could lose insurance once GOP lawmakers repeal the Affordable Care Act.

One of the top concerns is what will happen to individuals who became eligible for Medicaid with its expansion under Obamacare. The Senate's No. 2 Republican, however, promised that no one who got coverage under Medicaid expansion will lose it.

Read More →

President-elect Donald Trump told the audience at a luncheon Thursday that "I think in my mind I know who" my Supreme Court nominee is. He said that the announcement would come "within two to three weeks" of the start of his administration, according to cellphone video of his remarks obtained by CNN.

"I put out the list of 20, all highly responsible and highly talented, very talented judges ... Replacing somebody that was somebody I had great respect for as an intellect, Justice [Antonin] Scalia," Trump said, according to CNN.

The first part of the luncheon had been broadcast by the press pool, but the pool reporters had been escorted from the event before Trump's Supreme Court comments, CNN said.

Read More →

A handful of Republicans governors met Thursday with GOP senators who will be overseeing the repeal of Obamacare to express their concerns and hopes about the process. The meeting came after House Majority Leader Kevin McCarthy (R-CA) had asked governors across the country to weigh in on the effort to dismantle of the Affordable Care Act, including the Medicaid expansion, which some but not all red states had opted into.

Not surprisingly, many GOP governors said they supported repealing Obamacare, but some still warned against doing so swiftly without a replacement ready. Others highlighted the gains their states made under their Medicaid expansion.

Read More →

The $3 pill known as BiDil was already a difficult sell when a Georgia-based pharmaceutical company bought the marketing rights a few years ago. A treatment for African Americans suffering from heart failure, BiDil had never really caught on, forcing the drug company that developed it to take a buyout offer. One strike against the drug was a 2009 study that raised questions about its safety and effectiveness.

So last summer, the new owner of the drug, Arbor Pharmaceuticals LLC of Atlanta, sought to get the study taken down from a government website. For help, the company turned to the office of a congressman to whom the CEO had given the maximum $2,700 campaign donation 2014 Rep. Tom Price, the Georgia Republican nominated by Donald Trump to become head of the Department of Health and Human Services.

Read More →